Manerix 150 mg (Moclobemide TABLET) 150 MG

MANERIX 150 MG tablets contain moclobemide, an antidepressant used to manage mood disorders. This oral medication is manufactured by Bausch Health, Canada Inc.

Strength

150 MG

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MANERIX 150 MG tablets are primarily used for the management of depression and anxiety disorders. Moclobemide, the active ingredient, is classified as a reversible inhibitor of monoamine oxidase A (RIMA), which helps regulate mood. This medication is often prescribed to alleviate symptoms associated with mood disorders, promoting emotional well-being and stability.

Side Effects

Common effects of MANERIX 150 MG tablets may include improved mood and reduced anxiety. Some users may experience mild side effects such as dizziness, dry mouth, or gastrointestinal discomfort. These effects can vary depending on individual tolerance and dosage.

Precautions & Warnings

MANERIX 150 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid consuming alcohol or certain foods high in tyramine while taking this medication, as it may cause adverse reactions.

Avoid Interactions

MANERIX 150 MG tablets may interact with other medications, including certain antidepressants, pain relievers, and cold remedies. It is advisable to consult a healthcare professional before combining this medication with other treatments. Additionally, be cautious when consuming alcohol or foods rich in tyramine, as they can interact negatively with moclobemide.

Frequently Asked Questions

MANERIX 150 MG tablets are used to manage depression and anxiety disorders by regulating mood.

MANERIX 150 MG tablets are taken orally, typically as directed by a healthcare professional.

Common side effects may include dizziness, dry mouth, and gastrointestinal discomfort.

Consult a healthcare professional before combining MANERIX 150 MG with other medications to avoid potential interactions.

Avoid foods high in tyramine, such as aged cheeses and cured meats, as they can interact negatively with moclobemide.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.